Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban + Nimodipine for Early Neurological Deterioration in Small Artery Occlusive Cerebral Infarction
ChiCTR2500105760Phase 4Not yet recruiting
- Sponsor
- Xiushan Tujia and Miao Autonomous County People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tirofiban and nimodipine in brain infarction and Small-Vessel Occlusion (SVO) (2 arms), sponsored by Xiushan Tujia and Miao Autonomous County People's Hospital. Primary endpoint: Early neurological improvement within 1 week. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
tirofibannimodipine
03
Conditions
brain infarctionSmall-Vessel Occlusion (SVO)
Beyond the preview
Go deeper on ChiCTR2500105760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105760.